Apoptosis of HeLa and CaSki cell lines incubated with all-trans retinoid acid

Folia Histochemica et Cytobiologica

Volumn 47, Issue 4, 2009, Pages 599-603

  Darmochwal Kolarz, Dorota ^a   Gasowska Giszczak, Urszula ^b   Paduch, Robert ^c   Kolarz, Bogdan ^a   Wilciñski, Piotr ^a   Oleszczuk, Jan ^a   Kwasniewska, Anna ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b District Hospital of Lublin   (Poland)

^c MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

Author keywords

All trans retinoic acid; Apoptosis; CaSki cell line; HeLa cell line; Soluble APO 1 Fas antigen; Soluble ligand for APO 1 fas antigen

Indexed keywords

DIMETHYL SULFOXIDE; FAS ANTIGEN; FAS LIGAND; RETINOIC ACID;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL CULTURE; CELL LINE; CELL STRAIN CASKI; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME IMMUNOASSAY; HELA CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; NONHUMAN; PROTEIN SYNTHESIS; SUPERNATANT;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 77954408135     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10042-009-0113-0     Document Type: Article

References (25)

1. Peter ME, Krammer PH. Mechanisms of CD95 (APO-1/Fas) - mediated apoptosis. Curr Opinion Immunol. 1998;10:545-551.
2. Genestier L, Bonnefoy-Berard N, Revillard JP. Apoptosis of activated peripheral T cells. Transplant Proc. 1999;31:33-38.
3. Lynch DH, Ramsdell F, Alderson MR. Fas and FasL in the homeostatic regulation of immune responses. Immunol Today. 1995;16:569-574.
4. Wyllie AH. Death gets a break. Nature 1994;369:272-273.
5. Wyllie AH, Kerr JFR, Curie AR. Cell death: the significance of apoptosis. Inter Rev Cytol. 1980;65:251-306.
6. Nagata S, Golstein P. The Fas death factor. Science. 1995;267: 1449-1456.
7. Klaassen I, Brakenhoff RH, Smeets SJ, Snow GB, Braakhuis BJ. Considerations for in vitro retinoid experiments: impor- tance of protein interaction. Biochim Biophys Acta. 1999; 1427:265-275.
8. Raff MC. Social controls on cell survival and cell death. Nature. 1992;356:397-400.
9. Cheng J, Zhou T, Lin C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, Mountz J. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science. 1994;263: 1759-1762.
10. Suda T, Okazaki T, Naito Y. Expression of the Fas and Fas ligand in cells of T cell lineage. J Immunol. 1995;154:3806-3813.
11. Griffith TS, Fergusson TA. The role of FasL - induced apoptosis in immune privilege. Immunol Today. 1997;18:240-244.
12. Kwasniewska A, Tukendorf A. The concentrations of retinol in sera of women infected with HPV and with displastic changes of cervix. Med Dosw Mikrobiol. 1996;48:71-77.
13. Agarwal C, Hembree JR, Rorke EA, Eckert RL. Interferon and retinoic acid supress the growth of human papillomavirus type 16 immortalized cervical epithelial cells, but only inter- feron suppresses the level of human papillomavirus trans- forming oncogenes. Cancer Res. 1994;54:2108-2112.
14. Behbakht K, DeGeest K, Turyk ME, Wilbanks GD. All-trans retinoic acid inhibits the proliferation of cell lines derived from human cervical neoplasia. Gynecol Oncol. 1996;61:31-39.
15. Narayanan BA, Holladay EB, Nixon DW, Mauro CT. The effect of atRA and 9-cisRA on the steady state level of HPV 16 E6/E7 mRNA and cell cycle in cervical carcinoma cells. Life Sci. 1998;63:565-573.
16. Lagenfeld J, Kiyokawa H, Sekula D, Boyle J, Dmitrovski E. Posttranslational regulation of cyclin D1 dy retinoic acid: a chemoprevention mechanism. Proc. Natl Acad Sci USA. 1997;94:12070.
17. Teixeira C, Pratt M.A. CDK2 is a target for retinoic acid - mediated growth inhibition in MCF-7 human breast cancer cells. Mol Endocrinol. 1997;11:1191.
18. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J. 1996;10:940-954.
19. Sun SY, Yue P, Hong WK, Lotan R. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells. Cancer Research. 2000;60:6537-6543.
20. Lee MO, Kang HJ, Kim YM, Oum JH, Park J. Repression of FasL expression by retinoic acid involves a novel mechanism of inhibition of transactivation function of the nuclear factors of activated T-cells. Eur J Biochem. 2002;269(4):1162-1170.
21. Yano H, Fukuda K, Haramaki M, Momosaki S, Ogasawara S, Higaki K, Kojiro M. Expression of Fas and anti-Fas-mediat- ed apoptosis in human heaptocellular carcinoma cell lines. J Hepatol. 1996;25:454-464.
22. Mitani K, Nishioka Y, Yamabe K, Ogawa H, Miki T, Yanagawa H, Sone S. Soluble Fas in malignant pleural effusion and its expression in lung cancer cells. Cancer Sci. 2003;94: 302-307.
23. Zhu HL, Wang YZ, Yu L, Li B, Yao SQ, Lou FD. The expression of Fas, FasL and bcl-2 on RMA cells during the process of apoptosis induced by chemotherapeutic drugs. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2002;10(1):35-39.
24. Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Naipel F, Mattmann C, Burns K, Bodmer JL, Schroter M, Scaffidi C et al. Viral FLICE - inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature. 1997; 386:517-521.
25. Tschopp J, Thome M, Hofmann K, Meinl E. The fight of viruses against apoptosis. Curr Opin Genet Dev. 1998;8:82-87.